Thanks to a pilot project announced today by Microsoft, TracFone and Health Choice Network (here) we're about to find out. Set to launch in January, the pilot project is designed to test the theory that smartphones can lower costs and manage chronic conditions like diabetes with better health outcomes. One big [...]
When surveyed about their outlook, pharma industry leaders said they felt plagued by uncertainty and beaten down by budget cuts. More than half worried they would receive pink slips by the end of this year.
Are generic drugs still the bargain that everyone thinks? A new analysis finds that half of all generic drugs sold through retailers became more expensive over the past 12 months. In fact, the prices paid by pharmacies more than doubled for one out of 11 generics.
There are certainly a number of good business reasons for one pharmaceutical company to merge or acquire another. However, as I have often said in the past and, as can be seen in this case, mergers can have a negative effect on the R&D division of a company.
Pharmaceutical companies don’t have a particularly good reputation, for some very good reasons. But we can’t let suspicions about the motives of such companies cloud our assessments of drug safety because…
Cancer drug prices keep rising. The industry says this reflects the rising costs of drug development and the business risks they must take when testing new drugs. I think they charge what they think they can get away with, which goes up every year. Let’s consider the two arguments, and how [...]
After months of anticipation, MannKind has finally found a marketing partner for its inhaled insulin product. And the drug maker willing to bet the device can become a huge success is Sanofi, which hopes to plug a gaping hole in its diabetes strategy.
Medical bias comes in many forms. For the past couple of weeks, Dr. Robert Pearl has exposed conflicts of interest in medical research and radiation therapy. This week, he sets his sights to the economic motivations behind doctors buying and reselling drugs to their patients.
I must not be the only person to wonder how pharmaceutical companies succeed with direct to consumer advertisements when, stuck in the middle of all their TV ads, are those long lists of side effects. You know what I mean. After watching a smiling and attractive person running through a [...]
(Reuters) - Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its Incivek hepatitis C treatment, whose use has been largely supplanted by the new Sovaldi drug from Gilead Sciences Inc.On
With the tragic loss of Robin Williams to apparent suicide, a worldwide discussion about the effects of depression has begun. Untreated depression is the leading cause of suicide in the US, and suicide claims 34,000 lives in this country every year. Far too often those who would benefit from treatment don’t [...]
America’s biopharmaceutical research companies are developing 92 innovative new medicines to help the millions of Americans affected by arthritis. These medicines in development – all either in clinical trials or under review by the U.S. Food and Drug Administration– include 55 for rheumatoid arthritis, 15 for musculoskeletal pain, 10 for osteoarthritis and 7 for psoriatic arthritis, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).